Sangamo Therapeutics, Inc. (SGMO)
0.149
0.00 (0.00%)
USD |
OTCM |
Jun 10, 16:00
Sangamo Therapeutics Total Assets (Quarterly) : 59.96M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 59.96M |
| December 31, 2025 | 60.52M |
| September 30, 2025 | 88.64M |
| June 30, 2025 | 97.56M |
| March 31, 2025 | 86.17M |
| December 31, 2024 | 105.31M |
| September 30, 2024 | 111.26M |
| June 30, 2024 | 93.01M |
| March 31, 2024 | 128.96M |
| December 31, 2023 | 165.32M |
| September 30, 2023 | 219.70M |
| June 30, 2023 | 325.07M |
| March 31, 2023 | 440.57M |
| December 31, 2022 | 562.51M |
| September 30, 2022 | 593.91M |
| June 30, 2022 | 617.13M |
| March 31, 2022 | 654.31M |
| December 31, 2021 | 721.92M |
| September 30, 2021 | 772.40M |
| June 30, 2021 | 835.36M |
| March 31, 2021 | 877.10M |
| December 31, 2020 | 938.55M |
| September 30, 2020 | 963.71M |
| June 30, 2020 | 894.66M |
| March 31, 2020 | 584.28M |
| Date | Value |
|---|---|
| December 31, 2019 | 637.52M |
| September 30, 2019 | 640.22M |
| June 30, 2019 | 673.48M |
| March 31, 2019 | 542.73M |
| December 31, 2018 | 590.40M |
| September 30, 2018 | 606.60M |
| June 30, 2018 | 627.73M |
| March 31, 2018 | 281.17M |
| December 31, 2017 | 286.74M |
| September 30, 2017 | 269.79M |
| June 30, 2017 | 282.99M |
| March 31, 2017 | 146.81M |
| December 31, 2016 | 157.89M |
| September 30, 2016 | 164.98M |
| June 30, 2016 | 180.91M |
| March 31, 2016 | 197.05M |
| December 31, 2015 | 217.24M |
| September 30, 2015 | 232.52M |
| June 30, 2015 | 229.95M |
| March 31, 2015 | 238.50M |
| December 31, 2014 | 243.21M |
| September 30, 2014 | 247.35M |
| June 30, 2014 | 250.84M |
| March 31, 2014 | 255.50M |
| December 31, 2013 | 140.84M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| INmune Bio, Inc. | 25.82M |
| Bolt Biotherapeutics, Inc. | 48.03M |
| Arrowhead Pharmaceuticals, Inc. | 2.268B |
| Oncolytics Biotech, Inc. | 8.161M |
| Sarepta Therapeutics, Inc. | 3.179B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 78.92M |
| Shareholders Equity (Quarterly) | -18.96M |
| Debt to Equity Ratio | -1.020 |
| Current Ratio | 0.6985 |
| Net Debt Paydown Yield | 2.20% |